Cibus Appoints Craig Wichner as CEO to Accelerate Growth, Commercialization, and Shareholder Value

SAN DIEGO, June 8, 2026 — Agricultural biotechnology company Cibus, Inc. (NASDAQ: CBUS) has announced a major leadership transition aimed at supporting its next phase of commercial growth and long-term value creation. The company has appointed Craig Wichner, a recognized leader in agricultural investment and sustainable farming, as its new Chief Executive Officer. The move is part of Cibus’ previously announced succession planning strategy and comes at a critical stage as the company prepares to advance the commercialization of its gene-edited crop trait technologies.

A Strategic Leadership Transition for a Critical Growth Phase

Cibus stated that Craig Wichner, who joined the company’s Board of Directors in November 2025, will now assume the role of Chief Executive Officer. At the same time, Peter Beetham, who has served as Interim CEO for the past fifteen months, will continue as President and Chief Operating Officer (COO), focusing on operational execution and product development initiatives. As part of the reorganization, both Wichner and Beetham have stepped down from the company’s Board of Directors.

The leadership change reflects Cibus’ commitment to strengthening its executive team as it moves from technology development toward revenue generation and large-scale commercial deployment of its agricultural innovations.

Board Expresses Confidence in Wichner’s Leadership

According to Cibus Chairman Mark Finn, the board identified Wichner as an ideal candidate due to his unique combination of financial expertise, strategic insight, and deep agricultural industry experience.

Finn emphasized that Wichner demonstrated strong leadership during his tenure on the board and possesses a proven record of building value-driven organizations. The board believes his expertise will be instrumental as Cibus pursues near-term commercialization goals while simultaneously executing a long-term capital strategy designed to maximize shareholder returns.

Company leadership also praised Peter Beetham for guiding Cibus through a transformative period. During his tenure as Interim CEO, Beetham helped position the company for commercialization while securing more than $62 million in new investment capital. The board noted that his continued involvement as President and COO will ensure operational continuity and support a smooth leadership transition.

Craig Wichner Outlines Immediate Priorities

In his first statement as CEO, Wichner emphasized execution, commercialization, and disciplined capital management as his primary objectives.

He noted that when he joined the board, he recognized the company’s breakthrough gene-editing technology and clear pathway toward commercial success. His immediate focus will be on ensuring that Cibus' improved crop traits reach customers, converting commercialization milestones into revenue opportunities, and maintaining financial discipline throughout the process.

Wichner described the company as being at a pivotal moment, with significant opportunities to transform agricultural production through advanced biotechnology solutions.

Who Is Craig Wichner?

Craig Wichner brings extensive experience spanning agriculture, investment management, technology, and sustainable business development.

He is the Founder and Managing Partner of Farmland LP, a leading U.S. farmland investment management company overseeing more than $350 million in assets and approximately 19,000 acres of farmland. Since founding the firm in 2009, Wichner has become widely recognized for demonstrating how regenerative and organic farming practices can generate strong financial returns while improving environmental sustainability.

Prior to establishing Farmland LP, Wichner founded and managed multiple technology and investment companies focused on data-driven growth strategies. He also served on the board of BN Ranch, the successor company to Niman Ranch, before its acquisition by Blue Apron. His educational background includes a Bachelor of Science degree in Biochemistry and Molecular Biology with a minor in Economics from the University of California, San Diego.

Cibus’ Mission and Technology Platform

Cibus is a leading agricultural technology company specializing in the development and licensing of advanced plant traits for seed companies. Unlike traditional seed producers, Cibus focuses on creating genetic improvements that can be licensed to partners worldwide.

The company uses proprietary high-throughput gene-editing technologies to develop crop traits that address major agricultural challenges, including productivity, yield enhancement, sustainability, climate resilience, and input efficiency. These innovations are designed to help farmers produce more food while using fewer resources such as water, fertilizer, and crop protection products.

Cibus’ business model centers on licensing its trait technologies to seed companies in exchange for royalty-based revenue streams. This approach allows the company to scale globally without becoming a traditional seed manufacturer.

The Importance of Commercialization for Cibus

The appointment of a new CEO comes as Cibus enters one of the most important stages in its corporate development. After years of research and product development, the company is now focused on turning technological achievements into commercial success.

Industry analysts view commercialization as a critical milestone for biotechnology companies because it marks the transition from research-driven operations to revenue-generating business activities. Successful commercialization not only validates the underlying technology but also establishes a foundation for long-term profitability.

Under Wichner’s leadership, Cibus aims to accelerate the market adoption of its gene-edited traits while expanding strategic partnerships across the global agricultural sector.

Gene Editing and the Future of Agriculture

Gene editing is increasingly recognized as one of the most transformative technologies in modern agriculture. Unlike conventional breeding methods, gene-editing technologies allow scientists to make highly targeted changes to plant genetics, enabling the rapid development of desirable traits.

These traits can include improved drought tolerance, enhanced disease resistance, increased crop yields, better nutrient efficiency, and reduced environmental impact. As global populations continue to grow and climate-related challenges intensify, gene-editing solutions are expected to play an increasingly important role in ensuring food security and agricultural sustainability.

Cibus has positioned itself as a leader in this emerging sector by developing technologies that significantly reduce the time and cost associated with traditional crop improvement programs.

Investor Confidence and Capital Strategy

Another key responsibility for Wichner will be managing Cibus’ capital strategy. The board specifically highlighted his financial acumen and investment management experience as valuable assets in guiding the company through its next phase of growth.

As the company advances commercialization efforts, access to capital and disciplined resource allocation will remain essential. Wichner’s background in managing large-scale agricultural investments is expected to help Cibus balance innovation, operational execution, and shareholder returns.

Peter Beetham Continues to Play a Key Role

Although stepping aside as Interim CEO, Peter Beetham remains a central figure within the organization. As President and COO, he will continue overseeing day-to-day operations and supporting product development initiatives.

Beetham brings more than three decades of agricultural experience and has been involved with Cibus’ technology platform since its early stages. His scientific expertise and operational leadership are expected to complement Wichner’s strategic and financial strengths.

Industry Outlook for Agricultural Biotechnology

The agricultural biotechnology sector continues to experience rapid growth as farmers seek innovative solutions to improve productivity while reducing environmental impacts.

Challenges such as climate change, resource scarcity, population growth, and evolving consumer preferences are driving demand for advanced agricultural technologies. Gene editing, precision agriculture, regenerative farming practices, and digital farming platforms are among the innovations shaping the future of global food production.

Companies capable of successfully commercializing these technologies stand to benefit from significant market opportunities over the coming decades.

What This Means for Shareholders

For investors, the appointment of Craig Wichner signals a strong focus on execution and value creation. His experience in agriculture-focused investments and strategic business growth aligns closely with the company’s objectives of converting technological innovation into sustainable financial performance.

The board’s decision also reflects confidence that Cibus is approaching a pivotal commercial inflection point, where successful execution could unlock substantial long-term value.

Looking Ahead

As Cibus moves into its next chapter, the company faces both significant opportunities and important challenges. The successful commercialization of its gene-edited crop traits, expansion of licensing partnerships, and disciplined capital management will likely determine the pace of future growth.

With Craig Wichner now leading the organization and Peter Beetham continuing to oversee operations, Cibus appears positioned to strengthen its role within the rapidly evolving agricultural biotechnology industry.

The leadership transition represents more than a change in executive management—it signals the company's intention to accelerate growth, expand market adoption of its technologies, and create long-term value for shareholders, customers, and the broader agricultural ecosystem.

#Cibus #CraigWichner #AgriculturalBiotechnology #GeneEditing #SlimScan #GrowthStocks #CANSLIM